Xue Jie
Daemonorops draco Bl.
Also known as: Dragon's blood resin(English) 血竭(Chinese)
Hyeolgal血竭 혈갈 Hsüeh Chieh
Updated October 5, 2026 · Not yet clinically reviewed
Safety at a glance
With warfarin, coumadin, anticoagulant: blood-moving herb (活血化瘀) → possible additive bleeding risk; no clinical evidence for the class
3 recorded drug interactions, 1 major or contraindicated
Contraindications or side effects are listed
No toxicity grade is recorded. Most herbs in the catalogue carry none.
Traditional Chinese Medicine
- Category
- regulating blood
- Temperature
- Neutral
- Taste
- Sweet,Salty
- Channels
- Heart,Liver
Functions
Invigorates Blood and Alleviates Pain; Dispels Stasis and Stops Bleeding; Promotes Tissue Regeneration and Heals Sores
Traditional uses
Xue Jie (dragon's blood resin) is a warm, acrid herb that invigorates Blood and disperses stasis, relieves pain, stops bleeding, and generates new flesh in wound healing. It is used for pain from traumatic injuries, menstrual pain and irregularities from Blood stagnation, and the healing of sores and ulcers. Applied externally, it is one of the most important herbs for wound healing — stopping bleeding from lacerations while simultaneously promoting tissue regeneration and preventing infection.
Western herbalism
Properties: astringent, vulnerary, analgesic
Formulas using this herb
16 of 16 formulas
- Die Da Gao · 90.00000g
- Die Da Wan 跌打丸 · 30.00000g
- Duo Ming Dan · 15.00000g
- Huo Xue Zhi Tong Tang 活血止痛汤
- Jie Gu Dan · 4.80000g
- Jie Gu Wan · 30.00000g
- Lu Nei Xiao Yu Tang · 6.00000g
- Mei Hua Dian She Dan · 6.00000g
- Qi Li San 七厘散 · 30.00000g · chief
- Ren Shen Zi Jin Dan · 30.00000g
- Shen Deng Zhao Fa Fang · 6.00000g
- Wai Fu Jie Gu San
- Xi Po Zhi Bao Dan · 8.00000g
- Yao Tong Fang Yi Hao 腰痛方一号
- Zheng Gu Zi Jin Dan 正骨紫金丹 · 30.00000g
- Zhu Yu Tang 逐瘀汤
Botanical
Daemonorops draco (Willd.) Blume (Arecaceae) is a climbing rattan palm of Southeast Asia (Sumatra, Borneo, Malay Peninsula) with slender spiny stems several meters long that scramble through forest canopies, supported by spine-bearing whip-like cirri arising from the leaf sheaths. The ovoid scaly fruits exude a deep red resin between the scales; the fruits are harvested when ripe, vigorously shaken or steamed to dislodge the resin, which is then strained, melted, and cast into cakes or pieces known as 'dragon's blood' or Xue Jie in Chinese medicine. In TCM, Xue Jie is sweet and salty in flavor and neutral in nature, entering the Heart and Liver channels; it invigorates blood, dispels stasis, stops bleeding, alleviates pain, and promotes the healing of sores and wounds when applied externally.
- Family
- Arecaceae
- Pharmaceutical name
- Resina Draconis
- Parts used
- resin
- Plant type
- vine
Constituents
Dracorhodin
Flavylium (anthocyanidin-type) pigment · the Taiwan Herbal Pharmacopeia requires more than 1.0% dracorhodin in the resin
The red pigment used as the identity and assay marker for the palm-derived resin. It stimulates glucose uptake in mouse C2C12 muscle cells and primary rat aortic smooth muscle cells, and is one of the constituents behind the resin's wound-healing reputation, though the crude resin is more active than dracorhodin alone.
Dracorubin
Dimeric flavylium pigment
A second red pigment of the resin, formed from flavylium units. It contributes to the colour and to the chromatographic fingerprint that separates Daemonorops resin from Dracaena resin.
(2S)-5-Methoxyflavan-7-ol
Flavan
One of the three flavonoids proposed as quality-control indices for dragon's blood. Flavans are the class that chemically distinguishes the Daemonorops draco resin from Dracaena cochinchinensis resin, whose characteristic constituents are stilbenes instead.
(2S)-5-Methoxy-6-methylflavan-7-ol
Flavan
A quality-marker flavan of the resin. In UVB-irradiated HaCaT keratinocytes it was the most active of seven monomers isolated from Daemonorops draco, reducing IL-1 beta and TNF-alpha, reactive oxygen species and calcium influx.
Dracoresinotannol esters
Resin alcohol esters
The bulk, largely inert resinous matrix of the drug. It is why Xue Jie is dispensed as a fine powder or in alcohol rather than decocted, since the resin is poorly water-soluble.
Drug interactions
Dracaena resin sold as the same drug (Dracaena cochinchinensis, Dracaena cambodiana, Dracaena cinnabari)
Major · The material dispensed as Xue Jie is frequently not Daemonorops draco at all, so the constituent profile and most of the published clinical evidence do not apply to what is in the jar · Evidence level: Established
Two botanically unrelated resins share the trade name dragon's blood. UPLC-MS fingerprinting shows the profiles differ fundamentally: flavans dominate the Daemonorops draco resin while stilbenes dominate the Dracaena cochinchinensis resin, and MALDI-TOF was developed specifically to separate Daemonorops draco, Dracaena cinnabari and Dracaena cochinchinensis samples on the market. The Latin name Resina Draconis is in modern Chinese usage the Dracaena drug; the palm resin is properly Sanguis Draconis. Almost all human trial evidence published under Resina Draconis, including the diabetic foot ulcer trials, was generated with the Dracaena material and its markers loureirin A, loureirin B, resveratrol and pterostilbene, none of which occur in the palm resin.
Clinical note: Demand species-level identification on the certificate of analysis, and do not transfer Dracaena trial data to a Daemonorops prescription or the reverse. Dracaena cochinchinensis has been a nationally protected plant in China since 1987 and Dracaena cinnabari is IUCN Vulnerable, so sourcing pressure on the substitute is real.
Antiplatelet and anticoagulant drugs (aspirin, clopidogrel, warfarin)
Moderate · Possible additive inhibition of platelet aggregation and increased bruising or bleeding · Evidence level: Possible
Daemonorops draco resin is a direct platelet inhibitor. Against arachidonic-acid-induced aggregation it produced peak inhibition of 35.8% in rats at 200 mg/kg in vivo, and 18.7%, 20.0% and 61.6% inhibition in vitro at 0.2, 0.4 and 0.8 mg/ml, in each case more potent than the Dracaena resin tested alongside it. No human pharmacodynamic study of the interaction has been published, so the concern is extrapolated from the animal and in vitro data plus the drug's classical use to move blood.
Clinical note: Avoid or monitor closely in patients on antiplatelet or anticoagulant therapy, and stop before elective surgery. Note the classical paradox: Xue Jie is also used to stop bleeding topically, which does not protect against systemic antiplatelet effect when it is taken internally.
Insulin and oral hypoglycaemic agents
Moderate · Possible additive lowering of blood glucose · Evidence level: Possible
Crude dragon blood extract from Daemonorops draco and its constituent dracorhodin stimulated glucose uptake in mouse C2C12 muscle cells and in primary rat aortic smooth muscle cells, and oral administration of the crude extract produced a falling trend in fasting blood glucose in male B6 mice from the second to the tenth week. The effect was not attributable to dracorhodin alone. This is animal and cell data only.
Clinical note: Where Xue Jie is given internally to a diabetic patient, particularly alongside the diabetic-wound indications for which it is used, check capillary glucose more often in the first weeks.
Dosage
| Form | Amount | Frequency | Notes |
|---|---|---|---|
| powder or pills | 1–2 g | Daily | 中国药典 2020 【用法与用量】研末,1~2g,或入丸剂。外用研末撒或入膏药用。 【性味与归经】甘、咸,平。归心、肝经。 — Chinese Pharmacopoeia 2020, quoted verbatim; route and cautions preserved. Replaces a cleared category-filler value. |
Evidence
Study design on record, not certainty of outcome.
- In vitro / animal
- 4
Comparison of the chemical profiles and anti-platelet aggregation effects of two “Dragon's Blood” drugs used in traditional Chinese medicine
Yi T, Chen HB, Zhao ZZ, Yu ZL, Jiang ZH · Journal of Ethnopharmacology · 2011 · animal
In vitro / animal · Verified
UPLC-MS fingerprinting showed the resin of Daemonorops draco and the resin of Dracaena cochinchinensis have significantly different chemical profiles, with flavans characteristic of the former and stilbenes of the latter. Against arachidonic-acid-induced platelet aggregation the Daemonorops resin gave peak inhibition of 35.8% in rats at 200 mg/kg versus 27.6% for the Dracaena resin, and 18.7%, 20.0% and 61.6% inhibition in vitro at 0.2, 0.4 and 0.8 mg/ml versus 13.3%, 20.2% and 31.6%. The palm resin was the more potent antiplatelet drug of the two.
Hypoglycemic effects of dracorhodin and dragon blood crude extract from Daemonorops draco
Ching YH, Lin FM, Chen HC, Hsu CY, P'ng SY, Lin TN, Wang YC, Lin CJ, Chen YC, Ho TJ, Chen HP · Botanical Studies · 2024 · animal
In vitro / animal · Not yet verified
Dracorhodin and crude dragon blood extract from Daemonorops draco stimulated glucose uptake in mouse C2C12 muscle cells and primary rat aortic smooth muscle cells. Orally administered crude extract produced a decreasing trend in fasting blood glucose in male B6 mice from the second to the tenth week. The authors note that dracorhodin is not the only active compound and that the Taiwan Herbal Pharmacopeia sets a minimum of 1.0% dracorhodin for the drug.
Novel therapeutic activities of dragon blood from palm tree Daemonorops draco for the treatment of chronic diabetic wounds
Chen HC, You RI, Lin FM, Lin GL, Ho TJ, Chen HP · Botanical Studies · 2024 · in vitro
In vitro / animal · Not yet verified
Crude dragon blood extract from Daemonorops draco promoted differentiation of myoblasts into myotubes and partially purified fractions raised expression of the muscle differentiation genes myoG, myoD and myoHC. The work supports the resin's role as an ingredient of the topical formula Jinchuang Ointment used for chronic non-healing diabetic wounds, but it is cell-based work, not a clinical trial of the single herb.
Anti-inflammatory and barrier repair mechanisms of active components in Daemonorops draco Bl. for UVB-induced skin damage
Wu X, Zhang Y, Yi F, Geng Z, Guo M, Ling X, Li J, Li L · Scientific Reports · 2025 · in vitro
In vitro / animal · Not yet verified
Seven monomers were purified from Daemonorops draco and screened in UVB-irradiated HaCaT keratinocytes. (2S)-5-Methoxy-6-methylflavan-7-ol was the most active, lowering IL-1 beta and TNF-alpha expression and reducing reactive oxygen species and calcium levels, supporting the resin's traditional use for damaged skin and non-healing sores.
Safety
Contraindications
Its use is prohibited in pregnant women and female patients during the periods of menstruation, and it is not suitable for patients without blood stasis.
Source: Xi S, Gong Y. Essentials of Chinese Materia Medica and Medical Formulas. Academic Press/Elsevier, 2017, pp. 247–250.
Cultural and historical
Lei Gong Pao Zhi Lun · Northern and Southern dynasties
Xin Xiu Ben Cao (Tang Materia Medica) · Tang dynasty, 659
Ben Cao Gang Mu · Ming dynasty, 1596
References
- Yi T, Tang Y, Zhang J, Zhao Z, Yang Z, Chen H. Characterization and determination of six flavonoids in the ethnomedicine “Dragon’s Blood” by UPLC-PAD-MS. Chemistry Central Journal. 2012 doi:10.1186/1752-153X-6-116
- Wu C, Cai XQ, Chang Y, Chen CH, Ho TJ, Lai SC, Chen HP. Rapid identification of dragon blood samples from Daemonorops draco, Dracaena cinnabari and Dracaena cochinchinensis by MALDI-TOF mass spectrometry. Phytochemical Analysis. 2019 doi:10.1002/pca.2852
- Fan JY, Yi T, Sze-To CM, Zhu L, Peng WL, Zhang YZ, Zhao ZZ, Chen HB. A Systematic Review of the Botanical, Phytochemical and Pharmacological Profile of Dracaena cochinchinensis, a Plant Source of the Ethnomedicine “Dragon’s Blood”. Molecules. 2014 doi:10.3390/molecules190710650
- Lou J, Xu XY, Xu B, Wang HD, Li X, Sun H, Zheng XY, Zhou J. Comprehensive metabolome characterization and comparison between two sources of Dragon’s blood by integrating liquid chromatography/mass spectrometry and chemometrics. Analytical and Bioanalytical Chemistry. 2024 doi:10.1007/s00216-024-05159-2